Concentrix Corporation logo CNXC - Concentrix Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $33.50 DETAILS
HIGH: $45.00
LOW: $29.00
MEDIAN: $30.00
CONSENSUS: $33.50
UPSIDE: 29.09%

Stock News

Financial Review: Leidos (NYSE:LDOS) vs. Concentrix (NASDAQ:CNXC)

Financial Review: Leidos (NYSE:LDOS) vs. Concentrix (NASDAQ:CNXC)

Leidos (NYSE: LDOS - Get Free Report) and Concentrix (NASDAQ: CNXC - Get Free Report) are both industrials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends. Profitability This table compares Leidos and Concentrix's net margins, return

Oct 05, 2026 11:17 PM • defenseworld.net
Concentrix (NASDAQ: CNXC) Investor Alert: Johnson Fistel Investigates Following Revenue Outlook Cuts and $1.05 Billion Goodwill Impairment

Concentrix (NASDAQ: CNXC) Investor Alert: Johnson Fistel Investigates Following Revenue Outlook Cuts and $1.05 Billion Goodwill Impairment

SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, is investigating Concentrix Corporation (NASDAQ: CNXC) on behalf of investors who may have suffered losses. If you purchased Concentrix securities and suffered losses, please contact the firm to learn more about the investigation. There is no cost or obligation.

Oct 05, 2026 04:08 AM • globenewswire.com (Hide legal announcements)
Concentrix Q3: Not Impressed By The Numbers, Nor Surprised Share Price Is Down

Concentrix Q3: Not Impressed By The Numbers, Nor Surprised Share Price Is Down

Concentrix Corporation reported Q3 FY26 revenue of $2.45B, down 1.2% y/y, missing estimates, and issued a $1B goodwill impairment charge. CNXC's profitability remains pressured, with operating loss of $910M, but adjusted operating margin improved 30bps to 12.6% and interest coverage is healthy at 5.5x. Q3 results disappointed, with weak segment performance and a significant cut to FY26 and Q4 revenue guidance, driving a >10% post-market share drop.

Sep 30, 2026 05:01 AM • seekingalpha.com

Price Targets